Your browser doesn't support javascript.
loading
Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis.
Krueger, James G; Murrell, Dedee F; Garcet, Sandra; Navrazhina, Kristina; Lee, Patricia C; Muscianisi, Elisa; Blauvelt, Andrew.
Afiliação
  • Krueger JG; Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY. Electronic address: kruegej@mail.rockefeller.edu.
  • Murrell DF; Department of Dermatology, St George Hospital, University of New South Wales, Sydney, Australia.
  • Garcet S; Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY.
  • Navrazhina K; Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY.
  • Lee PC; Center for Clinical Studies, Webster, Tex.
  • Muscianisi E; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Blauvelt A; the Oregon Medical Research Center, Portland, Ore.
J Allergy Clin Immunol ; 147(3): 1107-1109.e2, 2021 03.
Article em En | MEDLINE | ID: mdl-33002515

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Pele / Anticorpos Monoclonais Humanizados / Enzima de Conversão de Angiotensina 2 / Anti-Inflamatórios Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Pele / Anticorpos Monoclonais Humanizados / Enzima de Conversão de Angiotensina 2 / Anti-Inflamatórios Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2021 Tipo de documento: Article